In patients with breast cancer YKL-39 was exclusively expressed in TAMs in tumor mass, and elevated levels of YKL-39 in primary tumors significantly correlated with metastatic relapse after therapy onset (6). The gene discussed is CHI3L2; the disease is breast cancer.